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We aimed to evaluate the effect of multi-ingredient nutritional supplementation,
with and without exercise training, on cognitive function in healthy older men.
Forty-nine sedentary men [age: 73 ± 6 years (mean ± SD); body mass index:
28.5 ± 3.6 kg/m2] were randomized to consume a supplement (SUPP n = 25; 1500 mg
n−3 polyunsaturated fatty acids, 30 g whey protein, 2.5 g creatine, 500 IU vitamin D,
and 400 mg calcium) or control beverage (CON n = 24; 22 g maltodextrin) twice daily for
20 weeks consisting of Phase 1: SUPP/CON followed by Phase 2: 12-week resistance
exercise training plus high-intensity interval training, while continuing to consume the
study beverages (SUPP/CON + EX). At baseline, 6 weeks, and 19 weeks we assessed
cognitive function [Montréal Cognitive Assessment (MOCA)], memory [word recall during
the Rey Auditory Verbal Learning Test (RAVLT)], executive functions (working memory
inhibition control), and nutrient bioavailability. We did not observe changes to any aspect
of cognitive function after Phase 1; however, significant improvements in the following
cognitive function outcomes were detected following Phase 2: MOCA scores increased
(6 weeks: 23.5 ± 3.3 vs. 19 weeks: 24.4 ± 2.5, p = 0.013); number of words recalled
during the RAVLT increased (6 weeks: 6.6 ± 3.6 vs. 19 weeks: 7.6 ± 3.8, p = 0.047);
and reaction time improved (6 weeks: 567 ± 49 ms vs. 19 weeks: 551 ± 51 ms,
p = 0.002). Although between-group differences in these outcomes were not significant,
we observed within-group improvements in composite cognitive function scores over
the course of the entire study only in the SUPP group (1 = 0.58 ± 0.62, p = 0.004)
but not in the CON group (1 = 0.31 ± 0.61, p = 0.06). We observed a progressive
increase in n−3 index, and a concomitant decrease in the ratio of arachidonic acid
(ARA) to eicosapentaenoic acid (EPA) within erythrocyte plasma membranes, in the
SUPP group only. At week 19, n−3 index (r = 0.49, p = 0.02) and the ARA:EPA
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ratio (r = −0.44, p = 0.03) were significantly correlated with composite cognitive
function scores. Our results show that 12 weeks of RET + HIIT resulted in improved
MOCA scores, word recall, and reaction time during an executive functions task;
and suggest that a multi-ingredient supplement combined with this exercise training
program may improve composite cognitive function scores in older men possibly via
supplementation-mediated alterations to n−3 PUFA bioavailability.
Clinical Trial Registration: http://www.ClinicalTrials.gov, identifier NCT02281331.
Keywords: resistance exercise training, high-intensity interval training, n−3 polyunsaturated fatty acids, protein,
creatine, vitamin D, calcium
INTRODUCTION
Dementia is an incurable and debilitating neurodegenerative
disorder that severely impairs cognitive function. Currently,
dementia affects approximately 50 million people worldwide,
however, this number is expected to reach 75 million by the
year 2030 (Prince et al., 2015). The impact of this cognitive
impairment is widespread and includes reductions in the ability
of affected persons to perform activities of daily living, and
increases in the financial and psychological burden on families
and caregivers (Alzheimer Society of Canada, 2010). Thus,
feasible and effective strategies to promote cognitive function and
delay the onset of dementia are needed.
Engaging in regular physical activity is associated with a
diminished risk of dementia (Barnes and Yaffe, 2011; Ginis
et al., 2017). Shorter term (12–24 weeks) exercise training
interventions have been shown to improve aspects of cognitive
function in older adults, such as executive functions, memory,
and processing speed (Smith et al., 2010). Although most research
to date has focused on low-to-moderate intensity aerobic exercise
training, higher intensity exercise may yield greater cognitive
benefits because it stimulates the production of more factors
that promote neuroplasticity, such as BDNF (Schmidt-Kassow
et al., 2012; Marquez et al., 2015). HIIT improves memory in
young adults (Heisz et al., 2017); however, this modality has
yet to be tested in older adults. RET has also been shown
to improve cognitive function (Liu-Ambrose and Donaldson,
2009). Importantly, improvements in cognitive function may be
enhanced when aerobic and resistance exercise are combined
(Colcombe and Kramer, 2003).
Nutrition is another modifiable lifestyle factor associated
with brain health in aging (Morris, 2012). Observational studies
report that populations consuming Mediterranean-style diets,
which contain foods rich in polyunsaturated fatty acids (PUFA)
Abbreviations: 1RM, one repetition maximum; ARA, arachidonic acid; BDNF,
brain-derived neurotrophic factor; BMI, body mass index; BP, blood pressure;
CON, control; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; FA,
fatty acid; HDL-c, high-density lipoprotein cholesterol; HIIT, high-intensity
interval training; HOMA-IR, homeostatic model of assessment of insulin
resistance; IL-6, interleukin-6; LDL-c, low-density lipoprotein cholesterol; MCI,
mild cognitive impairment; MOCA, Montréal Cognitive Assessment; n−3 PUFA,
omega-3 polyunsaturated fatty acid; OGTT, oral glucose tolerance test; RAVLT,
Rey Auditory Verbal Learning Test; RET, resistance exercise training; SUPP,
supplement; TEE, total energy expenditure; TG, triglycerides; TNF-α, tumor
necrosis factor alpha; VO2peak, peak oxygen uptake.
including omega-3 (n−3) PUFA, have lower dementia rates
(Scarmeas et al., 2006) and better cognitive function (Féart
et al., 2009) compared to populations consuming typical Western
diets. Furthermore, n−3 PUFA supplement may independently
prevent cognitive decline in older adults (Karr et al., 2011).
Higher intakes of vitamin D (with and without calcium) (Balion
et al., 2012), protein (van de Rest et al., 2013), and creatine
(Pilatus et al., 2009) are also associated with lower rates of
cognitive decline and dementia. However, the effects of n−3
PUFA, vitamin D, protein, and creatine supplementation on
cognitive function are not consistent across studies, and more
research is needed to understand the potential interactive
effects of these individual components (Calon, 2011). We
propose that combining multiple nutritional supplement with
an exercise training program that includes both RET and HIIT
components may lead to greater improvements in cognitive
function compared to each nutrient or intervention alone
(Dziedzic, 2006; Franceschi et al., 2007; Peake et al., 2010).
The objective of this study was to examine the effect of a
multi-ingredient nutritional supplement containing n−3 PUFA,
vitamin D (plus calcium), whey protein, and creatine (Bell
et al., 2017b), with and without exercise training, on circulating
concentrations of BDNF and cognitive function in a group
of healthy older men. A secondary objective was to evaluate
whether greater nutrient bioavailability was associated with
improvements in cognitive function. We hypothesized that,
compared to a control drink, our experimental supplement would
independently improve cognitive function as well as enhance
the typical beneficial effects of exercise training on cognitive
function and BDNF concentrations. We further hypothesized
that supplementation would increase vitamin D and n−3 PUFA
bioavailability; and that individuals with higher circulating n−3
PUFA at the end of the intervention would also demonstrate
greater improvements in cognitive function.
MATERIALS AND METHODS
Screening and Recruitment
The present study is a secondary analysis from a previously
published trial, which examined the effect of multi-nutrient
supplementation and exercise training on muscular strength (Bell
et al., 2017a,b). Briefly, 49 healthy older men took part in a
randomized, double-blind, placebo-controlled parallel group trial
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that was conducted between December 2014 and September
2016 at McMaster University. Potential participants were eligible
for the study if they: were non-smokers ≥ 65 years old;
were non-diabetic according to an OGTT, had a BMI in the
normal-overweight range, demonstrated normal cardiac function
during a maximal exercise stress test; and had not participated
in any structured resistance or aerobic exercise training program
in the past 6 months. Exclusion criteria included: regular
consumption of multi-vitamins, n−3 PUFA, whey protein,
creatine, calcium, or vitamin D supplements; significant weight
loss or gain in the past 6 months; regular use of non-steroidal
anti-inflammatory drugs, simvastatin, or anticoagulants; injuries
preventing safe participation in an exercise program; diabetes
mellitus; cancer; infectious disease; unstable cardiac; and/or
gastrointestinal disease.
The primary outcome of the previously published main
clinical trial was muscular strength, and as such, sample size was
calculated was based on this measure. An increase in leg press
isotonic strength of 3.25 kg (standard deviation: 1.5 kg) has been
observed during creatine supplementation combined with RET
in older adults, versus RET alone (Devries and Phillips, 2014).
We assumed a similar response variance in our subjects during a
2-way repeated measures ANOVA; with 80% power and α = 0.05,
we estimated needing a minimum of 19 subjects per group. To
account for a 20% dropout rate, we aimed to recruit 25 subjects
per group (50 subjects total).
This study was carried out in accordance with the
recommendations of the Canadian Tri-Council policy statement1
with written informed consent from all subjects. All subjects gave
written informed consent in accordance with the Declaration
of Helsinki. The protocol was approved by the Hamilton
Integrated Research Ethics Board. This trial was registered
at ClinicalTrials.gov (NCT02281331). The CONSORT flow
diagram illustrating the movement of subjects through the trial
can be found in Figure 1 (see Supplementary File S1 for the
accompanying CONSORT checklist).
Experimental Design
Participants were randomly assigned to receive either a multi-
ingredient nutritional SUPP (n = 25) or a control (CON,
n = 24) drink for 20 weeks, as depicted in Figure 2. After
6 weeks of consuming their study beverages at home (Phase 1:
SUPP/CON), subjects completed a 12-week supervised exercise
training program at McMaster University while continuing to
consume their assigned beverages (Phase 2: SUPP + EX and
CON + EX). We employed a coded (group A versus group
B) block randomization scheme (block size: 10 participants)
generated using www.randomization.com/ to sequentially
allocate subjects to groups in order of enrolment. A key to
the randomization code was held by an investigator (SMP)
who was not directly involved with subject recruitment,
training, or testing. Subjects, as well as investigators who
were responsible for recruiting, training, and/or testing
subjects, were blind to the individual group assignments.
At weeks −1 (baseline), 6, and 19 (post-intervention) we
1http://www.pre.ethics.gc.ca/pdf/eng/tcps2/TCPS_2_FINAL_Web.pdf
assessed aspects of cognitive function (including verbal
memory, executive functions, and processing speed). At
each timepoint, we obtained a blood sample the morning
after an 8–12 h overnight fast (no food or drink, except
for water). Participants refrained from strenuous physical
activity for at least 72 h prior to each blood draw. In these
blood samples we measured circulating concentrations
of BDNF and 25-hydroxyvitamin D [25(OH)D], as well
as the phospholipid composition of erythrocyte plasma
membranes. Plasma 25(OH)D concentrations and incorporation
of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
into erythrocyte plasma membranes reflect vitamin D and n−3
PUFA bioavailability, respectively, and indicate compliance
with the supplementation protocol as well as overall nutritional
health. Our primary outcomes of interest were circulating
BDNF concentrations and cognitive function; the secondary
outcomes were plasma 25(OH)D concentrations and erythrocyte
phospholipid composition.
Nutritional Supplements
Participants in the SUPP group consumed a multi-ingredient
beverage containing: 1,500 mg n−3 PUFA (which delivered
700 mg EPA and 445 mg DHA), 30 g whey protein, 500 IU
vitamin D, 2.5 g creatine, and 400 mg calcium, twice daily.
Participants in the CON group consumed a control beverage
containing 22 g of carbohydrate (maltodextrin) twice daily. The
exact composition of the SUPP and control drinks has been
previously outlined (Bell et al., 2017b). Subjects consumed their
first daily beverage within the hour after breakfast, and the second
1 h prior to bed. The control beverages were matched in volume
and flavor to the active blend. All study beverages were prepared
and labeled in a blinded manner by Infinit Nutrition (Windsor,
ON, Canada), and both subjects and researchers were blind
to individual group assignments. Participants were instructed
not to alter their habitual dietary or physical activity habits
(outside of supplementation and exercise sessions included in
the protocol) for the duration of the study. To verify adherence
to these instructions, participants completed 3-day food records
and circulating levels of EPA + DHA and 25(OH)D (see
section “Biochemical Analysis”) were evaluated at weeks −1,
6, and 19. At each of these timepoints, participants also wore
arm-mounted accelerometers (BodyMedia SenseWear Armband,
Cardinal Health Canada; Vaughan, ON, Canada) for 72 h to
assess habitual physical activity.
Exercise Training
From weeks 7 to 18, subjects engaged in a 12-week progressive
exercise training program at the Physical Activity Centre of
Excellence (PACE) at McMaster University. Details of the exercise
training program have been previously published (Bell et al.,
2017b). In brief, subjects completed three supervised exercise
sessions per week: whole body RET twice per week (Mondays
and Fridays) and HIIT on a cycle ergometer once per week
(Wednesdays). At every RET session, participants completed
two upper body (chest press and horizontal row on Mondays;
lateral pulldown and shoulder press on Fridays) and two
lower body exercises (leg press and leg extension on both
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FIGURE 1 | CONSORT flow diagram. This chart depicts the movement of participants through the trial, which we conducted between December 2014 and
September 2016.
Mondays and Fridays). Training was performed at 80% 1RM
(6–8 repetitions) for three sets, with the last set completed
until volitional fatigue. We chose this intensity and repetition
range because we have previously shown that heavy loads
stimulate greater improvements in muscular strength compared
to lighter loads in younger men (Mitchell et al., 2012), and
the primary objective of the main clinical trial was to induce
strength gains. Participants were allowed approximately 2 min of
rest between sets.
During their HIIT sessions, subjects completed 10 × 60 s
intervals cycling against a workload predetermined to elicit∼90%
maximal heart rate (HRmax) while maintaining a cadence of
≥90 rpm. HRmax was measured during an incremental exercise
test on a cycle ergometer at baseline (week −1), as well as
re-assessed immediately prior to the initiation of the RET+HIIT
program at week 6. We chose this HIIT protocol over the
more traditional Wingate-based (i.e., supramaximal) sprint
interval training commonly employed in younger adults, because
10 × 60 s HIIT has previously been shown to be well-tolerated
by sensitive populations such as sedentary overweight adults
(Gillen et al., 2013), and patients with type 2 diabetes (Gillen
et al., 2012) and cardiovascular disease (Currie et al., 2013).
HR was measured throughout each HIIT session using a chest
strap HR monitor (H7 Heart Rate Sensor; Polar Electro Canada;
Lachine, QC, Canada). Intervals were interspersed with 60 s of
rest where subjects cycled at a self-selected pace against 25 W.
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FIGURE 2 | Experimental design. Participants consumed either an experimental supplement (SUPP) or control (CON) beverage twice per day for 20 weeks (weeks
0–19, inclusive). Between weeks 7–18 (inclusive), participants completed a 12-week exercise training program. Exercise training consisted of RET twice weekly
(Mondays and Fridays) and HIIT once per week (Wednesdays). At weeks –1 (baseline), 6, and 19 we assessed cognitive function and obtained a blood sample for
the measurement of BDNF, 25(OH)D, and erythrocyte plasma membrane phospholipid composition. Phase 1: SUPP/CON took place between weeks 0–6, and
Phase 2: SUPP/CON + EX took place between weeks 7–19. SUPP, supplement; CON, control; RET, resistance exercise training; HIIT, high-intensity interval training;
BDNF, brain-derived neurotrophic factor; 25(OH)D, 25-hydroxyvitamin D.
All exercise sessions were supervised one-on-one by a member of
the research team.
Cognitive Function Assessments
Cognitive function assessments were conducted one-on-one
in a quiet room free from interruptions or distractions,
using standardized instructions, and primarily administered by
one investigator (HF). Each session began with the MOCA,
followed by the RAVLT. The RAVLT requires a 30 min delay
between Trials 6 and 7 (the immediate and delayed recall
tests, which measure short- and long-term verbal memory,
respectively), so during this interval participants completed the
executive functions and processing speed assessments on a
laptop computer2 (Presentation R©). The laptop assessments took
15–20 min to complete, and never caused the interval between
the RAVLT Trials 6 and 7 to exceed 30 min. All sessions
concluded with the RAVLT delayed recall and recognition tests.
In total, cognitive assessment sessions lasted approximately 1 h.
To minimize the chance of a learning effect at weeks 6 and 19,
three versions each of the MOCA and RAVLT were used in
a randomized order, so that each participant completed a new
version at each visit.
Montréal Cognitive Assessment
The MOCA (Nasreddine et al., 2005) evaluates a range of
cognitive functions including executive functions, memory,
language, and orientation, and may be used to identify
signs of MCI. Scores ≥ 26 (out of 30) are considered
normal for healthy adults, and scores < 26 indicate potential
cognitive impairment.
Verbal Memory
During the RAVLT (Rey, 1964) participants were instructed to
recall as many words as possible, in any order, from a 15-
word test list (List A) after listening to a research assistant
read the words aloud. This process was repeated 5 times (Trials
1–5), and each trial was scored based on the number of
words correctly recalled. Next, subjects listened to a different
15-word distractor list (List B) and were asked to recall as
2www.neurobs.com
many words as possible. Directly following this, participants
were asked to recall as many words as possible from List
A without hearing them again (immediate recall, Trial 6).
After a 30 min break (during which participants completed
the executive functions and processing speed assessments on
a laptop, as described below), participants were once again
asked to recall as many words as possible from List A without
hearing them again (delayed recall, Trial 7). The participants
were then presented with a visual recognition list of 30 words
(which included the 15 target words from List A) and asked
to circle the target words using a pencil. Memory outcomes
analyzed were the sum of words recalled during Trials 1–5
(short-term verbal memory), the number of words remembered
during the delayed recall test (Trial 7, long-term verbal memory),
as well as the number of words recognized from the visual
recognition list.
Executive Functions
The Go-NoGo Task assessed working memory inhibition control,
a measure of executive functions (Capuana et al., 2012).
Participants were presented with 120 uppercase letters in black
font appearing one at a time in the center of a white computer
screen. They were instructed to press the spacebar (“Go”) when
they saw any letter except four target letters (“NoGo”: J, D, V, or
M). These target letters comprised one third of the total number
of trials. A jittered presentation of a blank white screen preceded
the appearance of each letter for 500–1,000 ms, and the length
of time each letter appeared on screen was 500 ms. Outcomes
analyzed were accuracy (i.e., percentage of correct responses)
on the “Go” and “No-Go” trials, as well as reaction time on
correct “Go” trials.
Processing Speed
Processing speed was assessed using a Simple Reaction Time Task
(Clark et al., 2015) wherein participants were presented with 60
uppercase letters in black font appearing one at a time in the
center of a white computer screen. They were instructed to press
the spacebar as quickly as possible anytime a letter appeared
on the computer screen. As with the Go-NoGo Task, a jittered
presentation of a blank white screen preceded the appearance of
each letter for 500–1,000 ms, and the length of time each letter
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appeared on screen was 500 ms. Accuracy and reaction time were
the outcomes analyzed.
Biochemical Analysis
Whole blood was collected into evacuated tubes coated
with lithium heparin, and mixed by inversion. Immediately
after collection, tubes were centrifuged and the plasma
and erythrocyte layers separated. Fasting plasma 25(OH)D
concentrations were measured by radioimmunoassay (DiaSorin
Canada Inc.; Mississauga, ON, Canada), and fasting plasma
BDNF concentrations were measured using a Quantikine
Human Free BDNF ELISA kit (R&D Systems, Inc.; Minneapolis,
MN, United States).
An increase in the EPA and DHA content of erythrocyte
plasma membranes is detectable within 1 week during
supplementation with fish oil-derived n−3 PUFA (McGlory
et al., 2014). Increased membrane content of EPA, in particular, is
associated with decreased ARA, a pro-inflammatory eicosanoid
precursor (Calder, 2006). Erythrocyte membrane phospholipid
composition was measured from the erythrocyte layer as
described previously (Dirks et al., 2016). Briefly, total lipids
from the samples were extracted (Folch et al., 1957), and thin
layer chromatography was used to separate individual classes of
phospholipids. Once isolated, phospholipids were methylated
with 1 M methanolic sodium methoxide at room temperature
for 10 min (Mahadevappa and Holub, 1987), and the FA
composition of each class of phospholipids was analyzed by
gas chromatography (Hewlett-Packard 5890 Series II System,
equipped with a double flame ionization detector, and Agilent
CP-Sil 88 capillary column, 100 m, internal diameter of 0.25 mm)
(Nawrocki and Gorski, 2004; Bradley et al., 2008). FAs were
identified by comparing retention times to those of a known
standard, and absolute amounts of individual FAs were calculated
with the aid of an internal standard (pentadecanoic acid), which
was added to samples before the methylation process. Total
amounts of each phospholipid were determined from the sum
of FAs in each fraction. EPA + DHA content was determined
by summing the total amount of the EPA and DHA in all
phospholipid fractions. n−3 PUFA abundance was calculated as
the ratio of ARA to EPA (ARA:EPA) and as n−3 index as follows:
n− 3 index =
(
EPA+ DHA
total FA
)
× 100
Calculations
We computed a composite score that included each cognitive
outcome positively impacted by the intervention: MOCA scores,
delayed recall (Trial 7, long-term verbal memory) performance
on the RAVLT, and reaction time for correct “Go” trials during
the Go-NoGo Task. Each of these outcomes was first normalized
using their respective baseline means and standard deviations.
To match the interpretation of other cognitive outcomes (i.e.,
with higher values indicating better performance), reaction
times were reverse-scored. We then averaged together the
normalized values for each outcome to create a composite score
of composite cognitive function at weeks−1 (baseline), 6, and 19
(post-intervention).
Statistical Analysis
Statistical analysis was completed using SPSS (IBM SPSS
Statistics for Windows, version 23.0; IBM Corp., Armonk,
NY, United States). For all measures of cognitive function
(MOCA, verbal memory, executive functions, processing
speed, and composite cognitive function scores) and all
blood analyses [BDNF, plasma 25(OH)D concentrations, and
erythrocyte plasma membrane phospholipids] we conducted
an intention-to-treat analysis using a linear mixed model with
an unstructured covariance matrix, group and time as fixed
factors, and subject as a random factor. Age was included as a
covariate for all assessments of cognitive function (including
composite cognitive function scores) since it is an independent
factor related to cognitive performance. In the case of significant
group by time interactions, significant between (SUPP or CON)
and within (weeks−1, 6, or 19) group differences were identified
with Tukey’s post hoc test. Based on recommendations for
human clinical trials with missing data (Elobeid et al., 2009), all
participants (completers as well as participants who withdrew
prior to week 6 or week 19 testing) were included in the final
analyses, and missing values were not replaced. We examined
the effect sizes of the changes in measures of cognitive function
using Cohen’s D.
As an exploratory sub-analysis, we used one-sample
Student’s t-tests to evaluate whether the overall change (1
week 19-baseline) in composite cognitive function scores
was significantly different from no change (i.e., zero) in each
treatment group (SUPP and CON).
To explore whether consumption of the multi-ingredient
experimental supplement was associated with improvements in
cognitive function upon completion of the study, we conducted
two-tailed Pearson correlations between composite cognitive
function scores and the specific nutrients for which bioavailability
data was available: n−3 PUFA (erythrocyte phospholipid
composition) and vitamin D (plasma 25[OH]D3 concentrations).
In an effort to investigate whether one nutrient may exert a
greater effect on cognitive function, we then conducted two-
tailed partial correlations: (a) between composite cognitive
function scores and erythrocyte phospholipids, while controlling
for plasma 25(OH)D; and (b) between composite cognitive
function scores and plasma 25(OH)D, while controlling for
EPA+DHA content. All correlations were performed using data
collected at week 19. Although protein, calcium, and creatine
were also included in the experimental supplement, we were
unable to assess circulating concentrations of these nutrients.
As such, protein, calcium, and creatine were excluded from this
exploratory correlation analysis.
Data in text and tables are presented as mean ± SD. For all
statistical analyses, significance was accepted as p< 0.05.
RESULTS
Participants and Compliance
Of the 49 older men randomized, 38 completed the study. Four
subjects withdrew prior to week 6 testing (SUPP: n = 2; CON:
n = 2), and seven withdrew partway through the exercise training
Frontiers in Aging Neuroscience | www.frontiersin.org 6 May 2019 | Volume 11 | Article 107
fnagi-11-00107 May 9, 2019 Time: 16:4 # 7
Bell et al. Nutrition and Exercise Improve Cognitive Function
program, prior to week 19 testing (SUPP: n = 5; CON: n = 2).
Reasons for withdrawal are provided in Figure 1. Participants
were 73 ± 6 years (mean ± SD) of age and overweight
according to BMI (28.5 ± 3.6 kg/m2). There were no significant
differences in baseline physical characteristics between the SUPP
and CON groups (Table 1). Compliance with the nutrition
intervention (assessed via self-report as well as returned sachets)
and attendance during the exercise training program were>90%
in both the SUPP and CON groups.
Habitual Diet and Physical Activity
Detailed dietary intake data have previously been published (Bell
et al., 2017b). Briefly, n−3 PUFA, protein, vitamin D, and calcium
consumption all increased significantly by week 6 in the SUPP
group, and this increase was maintained throughout the rest
of the study. Macro- and micronutrient intake was unchanged
throughout the study in the CON group. Energy intake increased
(p = 0.004) and TEE decreased (p = 0.006) over time, with no
TABLE 1 | Baseline physical characteristics.
SUPP
(n = 25)
CON
(n = 24)
Age (years) 71 ± 5 74 ± 7
Systolic BP (mmHg) 138 ± 19 138 ± 15
Diastolic BP (mmHg) 78 ± 10 78 ± 8
Body mass (kg) 85.3 ± 12.2 84.5 ± 12.1
Height (m) 1.72 ± 0.07 1.72 ± 0.07
BMI (kg/m2) 28.9 ± 3.9 28.1 ± 3.4
Whole body lean mass (kg) 54.0 ± 5.4 54.5 ± 6.7
Whole body fat mass (kg) 28.2 ± 8.6 26.8 ± 6.8
% body fat 33.6 ± 6.4 32.6 ± 4.8
Leg extension 1RM (kg) 27 ± 7 27 ± 7
Leg press 1RM (kg) 77 ± 17 69 ± 21
VO2peak (mL/kg/min) 23.8 ± 4.2 24.4 ± 4.6
Peak power (W) 154 ± 25 158 ± 33
Fasting blood glucose (mM) 5.6 ± 0.6 5.8 ± 0.6
2 h blood glucose (mM) 6.8 ± 1.9 7.2 ± 2.1
HOMA-IR 2.1 ± 0.4 2.2 ± 0.5
Total-c (mM) 4.69 ± 1.08 4.83 ± 0.93
LDL-c (mM) 2.74 ± 1.02 2.87 ± 0.86
HDL-c (mM) 1.27 ± 0.31 1.29 ± 0.29
TG (mM) 1.49 ± 0.91 1.50 ± 1.04
Energy intake (kcal/d) 2146 ± 488 2336 ± 553
TEE (kcal/d) 2153 ± 318 2157 ± 627
AEE (kcal/d) 394 ± 258 374 ± 348
Average daily METs 1.3 ± 0.1 1.2 ± 0.3
Depression score1 3.2 ± 2.4 3.8 ± 3.6
MOCA score 23.0 ± 2.8 24.2 ± 2.4
1Assessed using the Geriatric Depression Scale (Yesavage et al., 1982). Data are
means ± SD. No significant differences between groups. AEE, active energy
expenditure; MET; metabolic equivalent; MOCA, Montréal Cognitive Assessment;
SUPP, supplement; CON, control; BP, blood pressure; BMI, body mass index;
1RM, one repetition maximum; VO2peak, peak oxygen uptake; HOMA-IR;
homeostatic model assessment of insulin resistance; c, cholesterol; LDL, low-
density lipoprotein; HDL, high-density lipoprotein; TG, triglyceride; TEE, total
energy expenditure.
difference between groups. Energy intake increased 10% in both
groups at week 6, with no further change following Phase 2. TEE
was unchanged in either group at week 6, and decreased 16%
following Phase 2.
Blood Analyses and Nutrient
Bioavailability
At baseline, n−3 index was significantly lower in the SUPP versus
CON group (p = 0.038; Table 2), but both groups fell within
the range generally associated with moderate cardiometabolic
health (i.e., n−3 index of 4.1–7.9%) (Harris and Von Schacky,
2004; Block et al., 2008). All other erythrocyte-based outcomes
(including EPA + DHA content) were similar between groups at
baseline. We observed significant group by time interactions for
plasma membrane EPA + DHA content, the ratio of ARA:EPA,
and n−3 index (all p < 0.001). In the SUPP group, EPA + DHA
content and n−3 index significantly increased 60–70% during
Phase 1, and a further 10–20% during Phase 2. The ratio of
ARA:EPA was significantly reduced following Phase 1, and this
reduction was maintained throughout Phase 2. In the CON
group, EPA + DHA content, n−3 index, and the ratio of
ARA:EPA did not change over the course of the study. At
weeks 6 and 19, EPA + DHA content and n−3 index were
significantly higher, and the ratio of ARA:EPA was significantly
lower, in the SUPP vs. CON group. Importantly, in the SUPP
group, n−3 index was ≥8.0% [the range associated with optimal
cardiometabolic health (Harris and Von Schacky, 2004; Block
et al., 2008)] at both of these timepoints. Total FA content did
not change in either group throughout the study.
At baseline, plasma 25(OH)D concentrations were not
statistically different between groups (SUPP: 44.3 ± 12.8 nM
and CON: 37.6 ± 13.8 nM; Table 2). On average, participants’
vitamin D status was below adequate, but not deficient [adequate:
plasma 25(OH)D> 50 nM; deficient: plasma 25(OH)D< 30 nM
(Institute of Medicine, 2011)]. We observed a significant group by
time interaction (p< 0.001) such that in the SUPP group plasma
25(OH)D concentrations increased 14% during Phase 1, and a
further 13% during Phase 2. As such, mean vitamin D status in
the SUPP group was considered adequate at weeks 6 and 19. In
the CON group, plasma 25(OH)D concentrations did not change
over the course of the study.
Baseline concentrations of plasma BDNF were not different
between groups (Table 2). We observed a main effect of time
(p = 0.007) whereby BDNF did not change during Phase
1, however, concentrations were reduced approximately 45%
following Phase 2, with no difference between groups. Despite
this, plasma BDNF was not significantly different between weeks
−1 and 19 (p = 0.127).
Cognitive Function
Montréal Cognitive Assessment
Prior to beginning the study, mean MOCA scores were below
normal cut-points (i.e., <26) in both groups (SUPP: 23.0 ± 2.8
and CON: 24.2 ± 2.4; Figure 3), and there were no between
group differences at baseline. We observed a main effect of time
whereby no changes occurred over the first 6 weeks of the study
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TABLE 2 | Blood analyses and nutrient bioavailability.
SUPP CON
−1 week 6 weeks 19 weeks −1 week 6 weeks 19 weeks
Erythrocyte plasma membrane
phospholipids
Total FA (pmol/mg Hb) 10,551 ± 1959 9792 ± 2048 9640 ± 2006 10,098 ± 1810 9259 ± 1790 9523 ± 1684
EPA + DHA (pmol/mg Hb)2 496 ± 107a 798 ± 294b∗ 882 ± 227c∗ 560 ± 128a 471 ± 129a 458 ± 123a
ARA:EPA2 140.4 ± 34.0a 68.8 ± 33.6b∗ 55.0 ± 47.9b∗ 127.5 ± 40.9a 146.9 ± 42.3a 150.6 ± 36.7a
n−3 index (%)2 4.7 ± 0.9a∗ 8.0 ± 1.6b∗ 9.3 ± 2.0c∗ 5.6 ± 1.2a 5.1 ± 0.9a 4.8 ± 0.9a
Plasma 25(OH)D (nM)2 44.3 ± 12.8a 50.5 ± 14.7b 57.1 ± 16.1c 37.6 ± 13.8a 37.3 ± 12.4a 35.6 ± 11.2a
BDNF (pg/mL)1 391 ± 443a,b 384 ± 418a 308 ± 240b 271 ± 331a,b 625 ± 507a 273 ± 203b
Data are mean ± SD. Different letters denote significant differences over time within each group. ∗Significant difference from CON at that time point. 1Main effect of time
(p = 0.007). 2Group-by-time interaction (p < 0.001). SUPP, supplement; CON, control; BDNF, brain-derived neurotrophic factor; FA, fatty acid; Hb, hemoglobin; EPA,
eicosapentaenoic acid; DHA, docosahexaenoic acid; ARA, arachidonic acid; n−3, omega-3; 25(OH)D, 25-hydroxyvitamin D.
FIGURE 3 | Montréal Cognitive Assessment performance. Scores of 26 or
more (out of a possible 30-point total) are considered normal; scores < 26
indicate possible MCI. Boxes (SUPP: gray; CON: white) represent interquartile
(25th to 75th percentile) ranges, with the horizontal lines indicating the
median. Whiskers represent the maximal and minimal values, and the cross
indicates the mean. Dissimilar letters denote changes over time within a given
treatment group (SUPP or CON). MOCA, Montréal Cognitive Assessment;
MCI, mild cognitive impairment; SUPP, supplement; CON, control.
(Phase 1), however, following the addition of the 12-week exercise
training program (Phase 2) we observed a 4% increase in MOCA
scores (SUPP: +7% and CON: +0%; p = 0.01). Although we
report no significant differences between groups at any point
in the study, the effect size of the improvement between weeks
6 and 19 was larger in the SUPP vs. CON group (Cohen’s
D: 0.53 vs. 0.02).
Verbal Memory
At baseline, there were no between group differences in any
RAVLT outcomes. We observed a group by time interaction for
delayed recognition performance (p = 0.02; Figure 4C), where
the number of words recognized in the SUPP group decreased
significantly by 7% at week 6 with no further change following
Phase 2. In the CON group, delayed recognition performance
was unchanged throughout the study. We observed a main effect
of time for long-term verbal memory: the number of words
recalled during Trial 7 (delayed recall; p = 0.047) did not change
over the first 6 weeks of the study (Phase 1), however, following
the addition of the 12-week exercise training program (Phase 2)
we observed a 15% increase in the mean number of words
recalled (SUPP: +19% and CON: +13%; Figure 4B), with no
difference between groups. We did not observe any change in
short-term verbal memory; the sum of words recalled during
Trials 1–5 did not change in either group over the course of the
study (Figure 4A).
Executive Functions
There were no between group differences in any executive
functions outcomes at baseline. We observed a main effect of time
for reaction time during correct “Go” trials during the Go-NoGo
Task (p = 0.002; Figure 5C) whereby no changes occurred over
the first 6 weeks of the study (Phase 1), however, following
the addition of the 12-week exercise training program (Phase
2) reaction time decreased approximately 5% (SUPP: −5% and
CON: −4%). Although we report no significant between group
differences following Phase 2, the effect size of the improvement
in reaction time during the Go-NoGo Task was larger in the SUPP
vs. CON group (Cohen’s D: −0.73 vs. −0.44). Accuracy during
the “Go” and “NoGo” trials was unchanged throughout the study
in either group (Figures 5A,B).
Processing Speed
Reaction time (SUPP: 289 ± 51 ms and CON: 300 ± 45 ms)
and accuracy (SUPP: 99 ± 1% and CON: 99 ± 2%) during the
Simple Reaction Time Task were not different between groups
at baseline, and did not change in either group over the course
of the study (p = 0.42 and p = 0.43 for reaction time and
accuracy, respectively).
Composite Cognitive Function
Composite cognitive function scores were similar between groups
at baseline. We observed a main effect of time (p < 0.001),
such that no change occurred during Phase 1, however, scores
increased by 0.46 (SUPP: +0.54 and CON: +0.40; data not
shown) over Phase 2, with no difference between groups.
In an exploratory sub-analysis we used one-sample t-tests to
examine whether the change in composite cognitive function
scores over the course of the entire study was significantly
different from no change (i.e., zero) in each group. We
observed a significant increase in composite cognitive function
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FIGURE 4 | Memory, assessed with the RAVLT. (A) Sum of words recalled during Trials 1–5 (out of a possible 75-word total). (B) Number of words recalled following
a 30 min delay (Trial 7; out of a possible 15-word total). (C) Number of words recognized in the 30-word visual recognition list (out of a possible 15-word total).
Boxes (SUPP: gray; CON: white) represent interquartile (25th to 75th percentile) ranges, with the horizontal lines indicating the median. Whiskers represent the
maximal and minimal values, and the cross indicates the mean. Dissimilar letters denote changes over time within a given treatment group (SUPP or CON). RAVLT,
Rey Auditory Verbal Learning Test; SUPP, supplement; CON, control.
FIGURE 5 | Working memory inhibition control (a measure of executive functions), assessed with the Go-NoGo Task. (A) Accuracy (i.e., percentage of correct
responses) during “Go” trials. (B) Accuracy during “NoGo” trials. (C) Reaction time during correct “Go” trials. Boxes (SUPP: gray; CON: white) represent interquartile
(25th to 75th percentile) ranges, with the horizontal lines indicating the median. Whiskers represent the maximal and minimal values, and the cross indicates the
mean. Dissimilar letters denote changes over time within a given treatment group (SUPP or CON). SUPP, supplement; CON, control.
scores in the SUPP group (1 week 19-baseline: 0.58 ± 0.62;
p = 0.004; Figure 6); but in the CON group, this increase
did not achieve statistical significance (1 week 19-baseline:
0.31± 0.61; p = 0.06).
Correlation Analysis
When subjects were collapsed across treatment group,
we observed a trend for a positive correlation between
end-of-study composite cognitive function scores and
erythrocyte plasma membrane EPA + DHA content, as
well as between composite cognitive function scores and
n−3 index. In line with this, composite cognitive function
scores and ARA:EPA at week 19 tended to be negatively
correlated (Table 3). There was no relationship between
composite cognitive function and circulating 25(OH)D
concentrations even after controlling for EPA + DHA
content. However, the correlations between composite
cognitive function and erythrocyte phospholipid composition
were statistically significant after adjusting for plasma
25(OH)D concentrations.
DISCUSSION
We observed that just 12 weeks of multi-modal exercise training
improved cognitive function in a group of previously inactive
but healthy older men. Bioavailability of certain components
of the experimental supplement (n−3 PUFA and vitamin D)
increased following 6 weeks of supplementation alone and
improved further with the addition of exercise training, yet
remained unchanged in the control group. Importantly, upon
completion of the exercise training program (at week 19),
higher bioavailability of n−3 PUFA was associated with greater
overall cognitive abilities. Taken together, our results show that
12 weeks of RET + HIIT improved MOCA scores, long-term
verbal memory, and executive functions in healthy older men;
and suggest that multi-ingredient nutritional supplementation
may have contributed to superior improvements in cognitive
function following exercise training, possibly via an EPA- or
DHA-dependent mechanism.
Consistent with prior research, the specific aspects of cognitive
function that benefited from our exercise training intervention
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FIGURE 6 | Change in composite cognitive function scores between baseline
and 19 weeks. Composite cognitive function scores were calculated using
MOCA scores, delayed recall (Trial 7) performance on the RAVLT, and reaction
time during correct “Go” trials during the Go-NoGo Task. Boxes (SUPP: gray;
CON: white) represent interquartile (25th to 75th percentile) ranges, with the
horizontal lines indicating the median. Whiskers represent the maximal and
minimal values, and the cross indicates the mean. ∗ indicates a significant
difference from no change (i.e., zero). SUPP, supplement; CON, control.
were executive functions and long-term verbal memory (Smith
et al., 2010). Reaction time became faster for the more complex
executive functions task (the Go-No-Go Task) but not for
the Simple Reaction Time Task (Smiley-Oyen et al., 2008).
This may reflect a ceiling effect for the Simple Reaction
Time Task, which produced consistently high accuracy scores
and fast reaction times even at baseline, leaving little room
for an intervention-related improvement. We also report a
training-related increase in performance on the MOCA, which
evaluates a broader range of cognitive functions and may be used
as a tool to screen for signs of MCI. At baseline our participants
were below normal cutoffs for the MOCA (<26) indicating
possible MCI (Nasreddine et al., 2005). Our intervention resulted
in average scores that were closer to normal, and in the
experimental group the proportion of subjects with MOCA
scores < 26 changed from 20/24 (83%) at baseline to 8/17 (47%)
at week 19. Conversely, in the control group, this proportion
was 16/23 (70%) at baseline and 13/18 (72%) at week 19.
Furthermore, the effect sizes of the improvements in the MOCA
and executive functions task were larger in the SUPP group.
Contrary to our hypothesis, however, we did not detect significant
group by time interactions in any of the individual cognitive
functions outcomes, most likely due to a lack of statistical power.
As such, we performed an exploratory sub-analysis to further
probe the relationship between supplementation, exercise, and
cognitive function. When the aspects of cognitive function
that were positively impacted by exercise training (MOCA
scores, long-term verbal memory, and reaction time during
the executive functions task) were combined into a composite
score, we observed that the change in cognitive performance
over the course of the study was significantly greater than zero
in the SUPP group, but not the CON group. This suggests
that multi-nutrient supplementation may yet be shown to have
a beneficial impact on cognitive function (and perhaps an
interactive effect with exercise training), however, more studies
are needed. We also observed moderate but significant changes
to energy intake and expenditure over the course of the study.
Total energy intake increased slightly over Phase 1, likely due
to supplementation, which added 100–200 kcal per day. The
decrease in TEE over exercise training (Phase 2) was most
likely due to participants reducing their habitual physical activity
outside of the training sessions, possibly due to muscle soreness
and/or fatigue. More intriguing, however, are the improvements
in cognitive function that occurred over as few as 12 weeks of
exercise training.
The relatively rapid change in cognitive function seen in
the present study may be related to the potentially additive
effects of exercise training combined with our nutritional
supplement containing ingredients known to positively impact
cognitive function (Scarmeas et al., 2018). After only 6 weeks
of supplementation alone we observed increased bioavailability
of certain nutrient components of the experimental supplement
(n−3 PUFA and vitamin D), with no change in the control
group. Although these initial changes were not accompanied
by improvements in cognitive function, individuals with an
erythrocyte plasma membrane phospholipid containing greater
EPA and DHA at the end of the study also demonstrated better
cognitive performance, after adjusting for circulating vitamin D.
These observations suggest, firstly, that n−3 PUFA may play a
larger role than vitamin D in effecting cognitive improvements
in older adults who are not vitamin D deficient. However,
since we were unable to measure the bioavailability of the full
complement of nutrients in our multi-ingredient supplement,
we do not know if n−3 PUFA is primarily responsible for
any potential nutrition-mediated improvements in cognitive
function. Secondly, our findings suggest that cognitive changes
may require a longer exposure to nutritional supplementation
or the addition of exercise training to become apparent.
Improvements in cognitive function were not detected until
the end of the study (i.e., after completion of the 12-week
RET + HIIT program). As such, we propose that the initial
6 weeks of the study (Phase 1: SUPP/CON) may not have
been enough time to alter brain function. Indeed, older adults
TABLE 3 | Pearson and partial correlations between composite cognitive function scores and bioavailable nutrients at week 19 (n = 25).
EPA + DHA content
(pmol/mg Hb)
n−3 index (%) ARA:EPA Plasma 25(OH)D (nM) Covariate
Composite 0.35 (0.09) 0.39 (0.06) −0.37 (0.07) −0.15 (0.43)a None
cognitive function 0.43 (0.04) 0.49 (0.02) −0.44 (0.03) – Plasma 25(OH)D
scores – 0.18 (0.39) −0.19 (0.38) −0.31 (0.14) EPA + DHA content
an = 30. Data are r (p). Significant correlations are bolded.
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may need to begin an exercise training program in a comparative
state of optimal nutrition (i.e., be “physiologically primed”) in
order for cognitive function to improve over such a short period
of time. This interpretation is consistent with animal models
that show reduced neuroplasticity with aging (Calabrese et al.,
2013), which would slow the rate of potential improvements
in brain function and cognitive function in response to the
beneficial effects of nutrition and exercise. Consumption of the
supplement alone for a period of more than 6 weeks would test
this hypothesis, and is an area for future research.
Our study raises important questions about the
potential interactive effects of multi-ingredient nutritional
supplementation and exercise training on cognitive function
in healthy older men, but additional studies are required.
Although we speculate that our observed improvements in
cognitive function were driven by the SUPP group, our statistical
analyses were underpowered to detect between group differences.
Post hoc sample size calculations revealed that upwards of 150
subjects per group would have been necessary to identify such
an effect. Furthermore, the experimental design of this study
allows us to account for and identify certain components of the
multi-ingredient supplement that appear most or least influential
but our certainty is limited by the design of our supplement.
Our correlation analysis was exploratory in nature, and the
relationship between n−3 PUFA, vitamin D, and cognitive
function should be further scrutinized in future studies. This
study was conducted on healthy older men who had the physical
and cognitive capabilities to complete a challenging RET+ HIIT
program. This challenging exercise intervention would likely
require modification before it could be applied in physically
and/or mentally impaired older adults. It is also impossible to
discount the potential beneficial effects of social interaction (due
to study assessments and exercise training sessions) on cognitive
function. Our placebo beverage was an effective nutritional
control, but subjects in the CON group received the same
amount of social interaction from members of the research
team as participants in the SUPP group. Future studies should
include a no-interaction control group to account for these
potential social effects. Lastly, including women in our study
would improve the generalizability of the results. We excluded
women from the main clinical trial (the primary outcome of
which was muscular strength) to improve the homogeneity of
our sample. Some prior work suggests the cognitive benefits from
exercise may be stronger in women than men (Colcombe and
Kramer, 2003), so the observed effects may be heightened in a
study that included women.
CONCLUSION
We report that an exercise training program that combined
RET+HIIT improved MOCA scores, long-term verbal memory,
and executive functions in a group of older men in as few as
12 weeks. Importantly, the RET + HIIT program was initiated
following 6 weeks of prior multi-nutrient supplementation. Our
observation of increased n−3 PUFA and vitamin D bioavailability
in the SUPP group, coupled with a positive correlation between
bioavailable n−3 PUFA and overall cognitive function, supports
the hypothesis that a multi-ingredient nutritional supplement
may enhance cognitive adaptations beyond exercise alone.
However, this speculation requires support from additional
studies. These results may help to inform the development of
a dementia invention strategy that uses physical activity with
or without nutritional supplementation to improve cognitive
functions for the growing number of older persons.
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